Citadel Health Continues to Grow Market Share in Australia
Citadel’s oncology information management system CHARM® maintains its position as market leader with several recent contract awards
We are proud to announce that our parent company have signed new agreements with several healthcare providers across Australia for the latest version of our oncology information system CHARM®.
CHARM® is a clinical oncology information system intended for use by multi-disciplinary cancer care clinicians for managing cancer treatments for patients. It assists with safe and efficient prescribing, dispensing, compounding or ordering, scheduling and administration of cancer treatments.
These new contracts signify our expanding market share and commitment to supporting the growing needs of patients and clinicians across Australia.
Citadel Health has been awarded contracts with:
- Far North Day Hospital
- Calvary St. John’s Hospital
- Loddon Mallee Rural Health Alliance
- Bass Coast Health
- St Andrews Toowoomba Hospital
Stephen Lynch, executive general manager at Citadel Health said: “We have maintained our status as a market leader because we steadfastly keep patients at the forefront of our minds. CHARM® is designed to improve outcomes for patients with cancer, and we will continue to deliver a valuable service to our customers now and in the future.”
About Citadel Health
Citadel Health, a subsidiary of The Citadel Group, provides market leading healthcare technology solutions. For more than 30 years, Citadel Health has specialised in creating and supporting several specialist applications including diagnostic pathology and medical oncology applications across both public and private health. Citadel Health is a trusted provider of a wide range of solutions and services that enable clients to optimise, integrate and innovate across their health operations.
https://citadelgroup.com.au/citadel-health/
